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Abstract
Introduction
Genes involved in body weight regulation that were previously investigated in genome-wide
association studies (GWAS) and in animal models were target-enriched followed by mas-
sive parallel next generation sequencing.
Methods
We enriched and re-sequenced continuous genomic regions comprising FTO,MC4R,
TMEM18, SDCCAG8, TKNS,MSRA and TBC1D1 in a screening sample of 196 extremely
obese children and adolescents with age and sex specific body mass index (BMI) 99th
percentile and 176 lean adults (BMI 15th percentile). 22 variants were confirmed by
Sanger sequencing. Genotyping was performed in up to 705 independent obesity trios
(extremely obese child and both parents), 243 extremely obese cases and 261 lean adults.
Results and Conclusion
We detected 20 different non-synonymous variants, one frame shift and one nonsense
mutation in the 7 continuous genomic regions in study groups of different weight extremes.
For SNP Arg695Cys (rs58983546) in TBC1D1 we detected nominal association with obe-
sity (pTDT = 0.03 in 705 trios). Eleven of the variants were rare, thus were only detected het-
erozygously in up to ten individual(s) of the complete screening sample of 372 individuals.
Two of them (in FTO andMSRA) were found in lean individuals, nine in extremely obese. In
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silico analyses of the 11 variants did not reveal functional implications for the mutations.
Concordant with our hypothesis we detected a rare variant that potentially leads to loss of
FTO function in a lean individual. For TBC1D1, in contrary to our hypothesis, the loss of
function variant (Arg443Stop) was found in an obese individual. Functional in vitro studies
are warranted.
Introduction
Obesity is one of the major health problems, which is associated with increased mortality and
morbidity [1]. To date more than 100 body mass index (BMI) associated loci have been pub-
lished from GWAS [2, 3, 4]. On the other hand, murine models have shown other relevant
genes for weight regulation which were not detected by GWAS (e.g. Tbc1d1 [5]). The aim of
this study is to identify functionally relevant mutations in genes involved in body weight regu-
lation derived from either GWAS or murine models. The rationale for the chosen genes is
briefly delineated in the following:
TBC1D1
In SJL mice a specific mutation in the Tbc1d1 gene (fsAla40474119) results in a truncated pro-
tein lacking the TBC Rab-GTPase-activating protein domain. The mutation led to resistance to
diet-induced obesity [5] and its causality for the phenotype was confirmed in Tbc1d1 knockout
mice [6, 7]. In mouse skeletal muscle cells, knockdown of Tbc1d1 increased fatty acid uptake
and oxidation whereas overexpression of Tbc1d1 had the opposite effect [5]. Mutations in the
human TBC1D1 gene are associated with increased risk for familial obesity [8, 9]. Polygenic
effects on BMI and waist circumference in humans were also described for some TBC1D1 SNP
alleles [10].
FTO
The fat mass and obesity associated gene (FTO) harbors GWAS derived polygenic variants
with the largest effect size on BMI (FTO; [3, 11]). The body weight of carriers of one risk allele
is increased by approximately 1.5 kgs. The effect of the risk alleles in intron 1 of FTO on body
weight had been replicated in most analyzed study groups, either across the whole life span [3,
11–14] or in all analyzed ethnic groups [11, 15, 16]. FTO is highly expressed in the hypothala-
mus which is the key region for control of food intake [17]. FTO belongs to a gene family that
is involved in post-translational modifications, DNA repair and fatty acid metabolism [18–20].
Fto deficient mice are lean as a consequence of increased energy expenditure [21] and show an
improvement in metabolic syndrome in comparison to leptin-deficient mice, wild type or het-
erozygotes for Fto [22]. Mice over expressing Fto showed a dose-dependent and diet-indepen-
dent increase in body weight and fat mass [23]. This is consistent with the finding that obesity
associated SNPs in intron 1 increase FTO expression in humans [24]. The same SNP in human
is associated with increased protein and lower overall energy intake [25].
TMEM18
The GWAS-derived gene TMEM18 is associated with increased BMI [11, 13, 26]. Besides obe-
sity, variants in TMEM18 are associated with earlier onset of menarche [27], metabolic syn-
drome [28], and increased waist to hip ratio [26]. The expression of Tmem18 in the prefrontal
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cortex is strongly and positively correlated with body weight in rats [26]. In humans, a methyl-
ation dependent elevated expression of TMEM18 in subcutaneous adipose tissue was associ-
ated with BMI and metabolic traits [29]. The transmembrane protein TMEM18 binds DNA
with its positively charged C-terminus that contains also a nuclear localization signal and is
likely involved in moving the chromatin close to the nuclear membrane [30].
SDCCAG8,MSRA and TNKS
We [13] previously described variants associated with early-onset extreme obesity in children
and adolescents. The loci are located near the serologically defined colon cancer antigen 8 gene
(SDCCAG8) and between the genes coding for tankyrase (TNKS) and for methionine sulfoxide
reductase A (MSRA). For these three genes, the role in the regulation of weight and energy
homeostasis is yet unknown. SDCCAG8 is involved in Bardet-Biedl syndrome; which is a syn-
dromal form of obesity [31, 32]. Variants in SDCCAG8 led to reduced weight loss in a group of
401 overweight and obese children and adolescents undergoing a lifestyle intervention [13] but
had no effect on weight regain after the intervention [33].
TNKS regulates the centrosome function [34] and telomere conservation [35]. Variants in
this gene are associated with type 2 diabetes [36] and several cancers (e.g. gastric cancer [37];
breast cancer [38]; colon cancer [39]; lung cancer [40]). MSRA catalyzes the enzymatic reduc-
tion of methionine sulfoxide to methionine. The latter is needed to repair oxidative damage of
proteins. Obesity is associated with oxidative stress caused by reactive oxygen species (ROS) in
the mitochondrion, with chronic excess of ROS that leads to mitochondrial dysfunction in
liver and skeletal muscle which contributes to insulin resistance [41]. Mice without Msra show
high-fat-diet-induced insulin resistance, most likely due to increased oxidative stress [42]. Var-
iants in MSRA were associated with increased waist circumference and waist-to-hip ratio in a
group of 3494 US Hispanic women [43]. Variants in both TNKS andMSRA did not affect
weight loss in the aforementioned weight loss group of 401 overweight and obese children and
adolescents [44] and had no effect on weight regain after the intervention [33].
Although heritability of body weight is high [45], GWAS could only detect a small fraction
of the assumed heritability. The 97 lead SNPs detected by the currently largest meta-analysis
of GWAS for BMI explain only approximately 5% of the total heritability of the variance of
BMI [3].
Here, we analyzed the coding region of genes relevant for body weight regulation derived
from GWAS (FTO,MC4R, SDCCAG8, TNKS/MSRA, and TMEM18) or animal models
(TBC1D1) via targeted re-sequencing for potentially causal variants involved in body weight
regulation. We used extreme phenotypes (196 individuals with the highest and 176 with the
lowest BMI of our previously described case control GWAS dataset; [12, 46]).
Material and Methods
Study group
The screening group consisted of individuals with the highest or lowest BMI, respectively,
of our previously described case control GWAS dataset [12, 13]. 196 extremely obese cases
(43.9% male, mean age 15.0 years, mean BMI 38.45 kg/m2, mean BMI SDS 3.11) and 176 lean
controls (52.0% male, mean age 24.74 years, mean BMI 18.15 kg/m2, mean BMI SDS -2.31)
were analyzed (Fig 1). All individuals were previously analyzed by GWAS (Affymetrix
Genome-Wide Human SNP Array 6.0) and were screened by dHPLC for mutations in the
MC4R [47].
Confirmation groups. (A) Family-based: A total of 705 obesity trios were used for confir-
mation. All detected non-synonymous, nonsense or frameshift variants were genotyped in an
Next Generation Sequencing in Genes for Weight Regulation
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Fig 1. Flowchart of the experimental setup.
doi:10.1371/journal.pone.0147904.g001
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independent study group of 355 obesity trios (index patients: 45.37% male, mean age 13.72 ±
3.12 years, mean BMI 31.75 ± 6.06 kg/m2, mean BMI SDS 4.13 ± 2.06; and both biological
parents; subgroup of a study group previously described [48]). The variants rs2279027
(TBC1D1 [Ser14Pro])), rs58983546 (TBC1D1 [Arg695Cys]), and rs34790717 (TNKS
[Gly237Ala]) were additionally genotyped in 350 independent obesity trios (total of 705 trios;
see [48]). (B) Case-control: The potentially functionally relevant variantMSRA [R6Efs88]
was additionally analyzed in 243 young extremely obese cases and 261 lean adult controls by
TaqMan assays ([12, 13], Fig 1).
Written informed consent was given by all participants and in case of minors by their
parents. The studies were approved by the Ethics Committees of the Universities of Marburg
and Duisburg-Essen and were performed in accordance with the Declaration of Helsinki.
Targeted Re-sequencing by Next-Generation Sequencing (NGS)
5 μg of genomic DNA was sheared to 200 bp by Covaris S2 instrument. 2 μg of sheared DNA
was subjected to paired-end library construction, namely end-repair, a-tailing, and amplifica-
tion with slight modifications [49]. Libraries were individually indexed and pooled prior to tar-
geted enrichment by Agilent SureSelect In-Solution Target Enrichment System. The complete
coding regions, including introns, of the genes FTO,MC4R, TMEM18, SDCCAG8, TKNS,
MSRA and TBC1D1 with 10kb 5’ and 3’ flanks to include potential regulatory regions were tar-
geted (S1 Table).
After target enrichment, the libraries were sequenced for 100 bp, using pair-end reads, on
an Illumina Genome Analyzer IIx. Read mapping on hg18 and variant calling was performed
using the same processing steps as described by Hu et al [50]. In order to reduce false-positive
calls only variants with a genotype score>20 were used for subsequent analyses. The raw data
were analyzed with pibase (http://www.ikmb.uni-kiel.de/pibase/index.html). For further analy-
ses, the complete exon regions of all protein forming splice variants (http://www.ensembl.org/
index.html, hg18) was extracted from the sequencing results. The analysis of 20 lean individu-
als failed during this process, so that the control group only consisted of 176 individuals.
TheMC4R was included in the analysis despite being previously screened with an indepen-
dent method (dHPLC, Sanger re-sequencing, [47]) to serve as a control for the used NGS pro-
tocol. Prior to analysis of theMC4R variants, the validity threshold for non-synonymous
variants was set to a genotype score of ‘20’ ([50], which was a conservative threshold to rather
include false positive variants, than to miss an existing mutation. With this threshold, a total of
19 variants were detected inMC4R (S2 Table). The NGS results were not corrected for failed
samples or low coverage. These 19 variants detected by NGS were compared to the initial
results of the dHPLC/Sanger re-sequencing approach. Deviant results were validated with
additional Sanger re-sequencing. Of the 19 initial variants (threshold 20), only 5 could be con-
firmed by the independent methods. All variants that could not be reproduced by Sanger
sequencing had a score below ‘100’. Hence, we decided to use a score of ‘100’ as a threshold for
analysis of the NGS data for all analyzed genes.
Variant verification
All detected non-synonymous variants (Table 1) with minor allele frequencies below one per-
cent were uni-directionally Sanger re-sequenced. At least two experienced individuals indepen-
dently assigned the genotypes; discrepancies were resolved by reaching consensus or by re-
sequencing. The primers for the PCRs can be obtained from the authors.
Next Generation Sequencing in Genes for Weight Regulation
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In silico functional analysis
All non-synonymous variants were in silico analyzed with MutationTaster (http://www.
mutationtaster.org/ [51]), PMUT (http://mmb.pcb.ub.es/PMut/ [52]), PolyPhen-2 (http://
genetics.bwh.harvard.edu/pph2/ [53]), and SNAP (https://www.rostlab.org/services/SNAP/
[54]) for potential functional impact on the protein level.
Genotyping for association analysis
All detected non-synonymous variants were genotyped in 355 obesity trios via MALDI TOF.
The variants rs2279027 (TBC1D1 [Ser14Pro]) and rs58983546 (TBC1D1 [Arg695Cys]) were
analyzed by TaqMan Assay (C___1673024_1_ and C__89662374_10, respectively) and the
variant rs34790717 (TNKS [Gly237Ala]) by PCR-RFLP (Primers F 3’-GGCAAACGTAAATG
CAAAGG-5’ and R 3’-CCTCACCAGAAGACTGGAGG-5’; digest of the C-allele withMwo1)
in 350 independent obesity trios. The variant TMP_ESP_8_9912039 (MSRA [R6Efs88]) was
additionally genotyped by a custom TaqMan SNP Genotyping Assay (AHZAE78) in 243
extremely obese children and adolescents and 261 lean adult controls.
Statistical analysis
At the start of the screening we decided to genotype the detected non-synonymous, frameshift
and nonsense mutations in 355 independent obesity trios to identify potential transmission
disequilibrium [55] for the analyzed variants. At that time, we did not know the allele frequen-
cies of the variants to be detected, hence power calculations could not be performed. The TDT
procedure was previously very successful in our hands for infrequent variants (1–3% allele fre-
quency). For instance, we detected significantly reduced transmission of the infrequent allele at
theMC4R Val103Ile polymorphism to obese children in a relatively small number of obesity
trios (n = 520 [56]). We were the first group to describe the polygenic weight lowering effect
of the MC4R 103Ile allele; previous case control association studies did not identify the small
effect. Hence we regard the trio approach as especially powerful for variants with a low fre-
quency, as stratification effects are mainly eliminated [55]. SNPs with tentatively low p-values
in the 355 trios were genotyped in an additional 350 further obesity trios, so that a total of 705
obesity trios was screened for promising SNPs.
Association to obesity was analyzed by standard statistical programs (case-control: Fisher’s
exact test from Excel, obesity trios: transmission-disequilibrium test in Excel [55]. All reported
p-values are nominal, uncorrected and two-tailed.
Table 1. Number of detected variants per gene (FTO, TMEM18, SDCCAG8, TKNS,MSRA and TBC1D1) in 196 extremely obese children and adoles-
cents and 176 lean adults.
Gene Length cDNA [kb] Variants total Variants per kb Non synonymous variants NS variants per kb InDels InDels per kb
FTO 11,766 6 0.51 3 0.25 0 NA
MSRA 1,706 4 2.92 3 2.34 1 0.59
SDCCAG8 2,567 6 2.33 2 0.78 0 NA
TBC1D1 5,700 17 2.98 11 1.93 0 NA
TMEM18 2,762 1 0.36 0 NA 0 NA
TKNS 9,620 14 1.46 2 0.21 0 NA
doi:10.1371/journal.pone.0147904.t001
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Results
Screening procedure and quality control
We aimed to identify new mutations by targeted re-sequencing in the continuous genomic
regions of seven genes involved in weight regulation. We used a screening sample of 196 obese
and 176 lean individuals of different weight extremes; detected variants were confirmed in 355
independent obesity trios, SNPs with a nominal p-value below 0.05 were genotyped in a total
of 705 obesity trios (355 plus 350 trios). Additionally, for the variantMSRA [R6Efs88] which
likely confers a functional effect, we analyzed 243 young extremely obese cases and 261 lean
adult controls ([12, 13], Fig 1) on top of the 705 trios.
MC4R was used as a reference gene to define a validity score for the initial discovery of vari-
ants derived from re-sequencing of enriched genomic regions (S2 Table). We hence used the
genotype score ‘100’ [50] for the remaining genes TBC1D1, FTO, TMEM18, SDCCAG8, TKNS,
andMSRA (Table 1).
Mutational analysis of TBC1D1, FTO, TMEM18, SDCCAG8, TKNS, and
MSRA
A total of 49 variants (48 non-synonymous and 1 frameshift, S2 Table) were detected in the
sample of 196 extremely obese children and adolescents and 176 lean adults within the 6 genes
(FTO, TMEM18, SDCCAG8, TKNS,MSRA and TBC1D1). Of these, 32 variants were known
SNPs as listed in the dbSNP. The others were yet not described in the accessible databases (data
access for all: November 9th 2015: EVS: http://evs.gs.washington.edu/EVS/, 1000Genomes:
http://browser.1000genomes.org/index.html, dbSNP: http://www.ncbi.nlm.nih.gov/snp/, and
ExAC: http://exac.broadinstitute.org/variant/). The previously unknown variants had a minor
allele frequency below 0.001 and were detected heterozygously in all cases (Table 2). The 22
non-synonymous and frameshift variants detected in the sample were Sanger re-sequenced;
only one could not be confirmed (TNKS Asn1103Lys).
Confirmation and genotyping in large independent study groups
Genotyping was performed in up to 705 obesity trios plus 243 young extremely obese cases and
261 lean adult controls [12, 13] independent of the screening sample. All detected non-synony-
mous, nonsense and frameshift variants were genotyped by MALDI-TOF in 355 independent
family-based obesity trios. As most of these variants were rare, nine of the 21 could not be
detected in the additional sample. None of the variants showed transmission disequilibrium
for obesity in the 355 obesity trios (Table 3).
Only a few of the detected non-synonymous variants were in silico predicted to behave like
the wild type protein (FTO [Cys9Tyr],MSRA [Asp142Tyr] andMSRA [Gly187Ser]). For all
others, an altered protein function was predicted (Table 4; Mutation Taster).
TBC1D1. Of the 17 variants detected in TBC1D1, eleven were non-synonymous. The SNP
Arg695Cys (rs58983546) was not associated with obesity in the initial sample (p = 1), but nom-
inally associated in the 355 obesity trios (nominal p = 0.05). We added 350 independent trios
and confirmed the association of the minor allele with obesity (nominal p for the complete
set of 705 trios = 0.03). The variant is located in a domain of unknown function (DUF3350;
PFAM) of TBC1D1; minor allele frequency is 1.25% in CEU (“Utah residents with ancestry
from northern and western Europe”, dbSNP).
The stop gain variant TBC1D1 Arg443 was only detected once in an extremely obese het-
erozygous carrier (Table 4) out of a total of 551 obese and 419 lean individuals. A mutation
Next Generation Sequencing in Genes for Weight Regulation
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leading to a stop codon would result in a loss of the Rab-GTPase-TBC domain which would
result in a complete loss of function.
FTO. Of the six detected variants in FTO, three were rare and non-synonymous (Table 2).
These were found in either obese or lean individuals. Interestingly one mutation (Ala163Thr)
was detected in two independent obese individuals, implying cryptic relatedness between these
mutation carriers [57]. The variant was previously described by Meyre et al. [58] in both obese
and lean subjects. The variant is located in a surface loop of FTO but was not tested in vitro for
functional effects. In silico predictions for this variant were variable (Table 4). The other novel
FTO variant Val83Leu was detected heterozygously in a lean female. It is located in the sub-
strate recognition lid of the protein and in silicomethods predict a highly likely functional out-
come (Table 4).
TMEM18. None of the variants in TMEM18 altered the amino acid sequence.
SDCCAG8. Of the six variants detected in SDCCAG8, two were non-synonymous. Both
are previously known SNPs (rs2275155 [Glu378Asp], rs79435766 [Thr398Met]). The latter
Table 2. Non-synonymous, stop and frameshift variants1 detected by NGS of the genes FTO, TMEM18, SDCCAG8, TKNS,MSRA and TBC1D1 in
196 extremely obese children and adolescents and 176 lean adults.
Obese Lean
Gene Variant Effect on
amino acid
level
MAF
in
CEU2
11 12 22 pHWG 11 12 22 pHWG p-
value
OR In silico
functional
prediciton
FTO rs144100465 Cys9Tyr 0.000 196 0 0 1.00 175 1 0 0.97 1 NA Polymorphism
FTO Val83Leu 0.000 195 1 0 0.97 176 0 0 1.00 1 NA disease causing
FTO rs145884431 Ala163Thr 0.003 194 2 0 0.94 176 0 0 1.00 0.33 0.22 disease causing
SDCCAG8 rs2275155 Glu378Asp 0.275 158 32 6 0.01 155 17 4 0.00 0.97 0.53 disease causing
SDCCAG8 rs79435766 Thr398Met 0.000 195 1 0 0.97 176 0 0 1.00 1 NA disease causing
TNKS rs34790717 Gly237Ala 0.371 149 44 3 0.90 123 51 2 0.19 0.79 1.36 disease causing
TNKS Pro275Ala NA 195 1 0 0.97 176 0 0 1.00 1 NA disease causing
MSRA TMP_ESP_8_9912039 Arg6Glufs*88 0.009 195 1 0 0.97 176 0 0 1.00 1 NA disease causing
MSRA rs6601444 Thr88Met 0.197 151 43 2 0.58 144 27 5 0.01 0.97 0.75 disease causing
MSRA Asp142Tyr 0.000 195 1 0 0.97 176 0 0 1.00 1 NA Polymorphism
MSRA rs201155438 Gly187Ser 0.000 195 1 0 0.97 176 0 0 1.00 1 NA Polymorphism
TBC1D1 rs2279027 Ser14Pro 0.325 113 65 29 0.00 117 54 20 0.00 0.18 0.76 disease causing
TBC1D1 rs35859249 Arg125Trp 0.139 173 23 0 0.38 157 18 1 0.54 0.775 0.91 disease causing
TBC1D1 rs112261209 Arg327Lys 0.012 191 5 0 0.86 173 3 0 0.91 0.596 0.66 disease causing
TBC1D1 rs61731607 Ala384Pro 0.042 189 7 0 0.80 174 2 0 0.94 0.148 0.31 disease causing
TBC1D1 rs61731610 Gly389Ser 0.041 190 6 0 0.83 174 2 0 0.94 0.220 0.36 disease causing
TBC1D1 Arg443* 0.000 195 1 0 0.97 176 0 0 1.00 1 NA disease causing
TBC1D1 rs145177739 Gln619Arg 0.000 195 1 0 0.97 176 0 0 1.00 1 NA disease causing
TBC1D1 rs58983546 Arg695Cys 0.118 168 28 0 0.28 151 24 1 0.97 0.982 0.99 disease causing
TBC1D1 Leu838Val NA 195 1 0 0.97 176 0 0 1.00 1 NA disease causing
TBC1D1 rs376683121 Arg1091His 0.000 195 1 0 0.97 176 0 0 1.00 1 NA disease causing
TBC1D1 rs13110318 Arg1136Gln 0.094 191 5 0 0.86 175 1 0 0.97 0.166 0.22 disease causing
AA: Amino acid; pHWG: p value of the Hardy Weinberg disequilibrium (deviations from HWG are marked in bold); NA: not available; p-value is calculated
with Fisher’s exact test; OR: Odd’s Ratio
1score >100
2 Minor allele frequency (MAF) taken from http://exac.broadinstitute.org/, European cohort.
doi:10.1371/journal.pone.0147904.t002
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variant was found in an extremely obese male adolescent (Table 4). The variant is located in a
coiled coil domain. In silico functional prediction for this variant was variable (Table 4).
TNKS. In TNKS, only 2 of 14 detected variants were non-synonymous. One of them
was a previously known SNP (rs34790717 [Gly237Ala]), while the other one was previously
unknown (TNKS [Pro275Ala]). The rare variant TNKS [Pro275Ala] was detected in an
extremely obese female. However, in silico predictions for this variant mainly implied no func-
tional effect on protein level (Table 4).
MSRA. InMSRA we identified a frameshift mutation (Arg6Glufs88;
TMP_ESP_8_9912039) in an extremely obese female (age 13.6 years, BMI 42.67 kg/m2, 100th
age and sex specific BMI percentile, Table 4). Within the 355 obesity trios the variant was
detected in an additional unrelated father. This obese carrier (male, age 45 years, BMI 35 kg/
m2) did not transmit the variant to his extremely obese offspring. We also screened for the
frameshift mutation in an independent sample of 243 extremely obese children and adolescents
and 261 lean adult controls. Here, the variant was detected in a normal weight adult female
(age 26.8 years, BMI 21.3 kg/m2) and a lean adult male (age 24.3 years, BMI 16.5 kg/m2).
Hence, in sum a strong relevance of this variant for body weight regulation is unlikely. Addi-
tionally, three non-synonymous variants were detected (MSRA rs6601444 [Thr88Met],
[Asp142Tyr], and rs201155438 [Gly187Ser]). One of these [187Ser] was found in an extremely
obese male adolescent; the other [142Tyr] in a lean participant (Table 4). Both mutations are
Table 3. Transmission disequilibrium test of the 22 variants detected by NGS in 355 German obesity trios.
EAF
Gene Variant Effect on amino acid level Alleles Index Parents OR p-value
FTO rs144100465 Cys9Tyr A/G 1.15% 1.02% 1.333 0.71
FTO Val83Leu G/T 0.00% 0.00% NA NA
FTO rs145884431 Ala163Thr A/G 0.85% 0.71% 1.5 0.65
SDCCAG8 rs2275155 Glu378Asp A/T 46.46% 44.91% 1.082 0.49
SDCCAG8 rs79435766 Thr398Met C/G 0.00% 0.00% NA NA
TNKS rs34790717 Gly237Ala C/G 37.61% 39.16% 0.913 0.46
TNKS Pro275Ala C/G 0.00% 0.00% NA NA
MSRA TMP_ESP_8_9912039 Arg6Glufs*88 CC/— 0.00% 0.00% NA NA
MSRA rs6601444 Thr88Met C/T 35.65% 37.76% 1.012 0.57
MSRA Asp142Tyr G/T 0.00% 0.00% NA NA
MSRA rs201155438 Gly187Ser A/G 0.00% 0.00% NA NA
TBC1D1 rs2279027 Ser14Pro A/G 48.72% 50.88% 0.6 0.32
TBC1D1 rs35859249 Arg125Trp C/T 16.76% 18.92% 1.082 0.66
TBC1D1 rs112261209 Arg327Lys A/G 2.27% 1.60% 2.333 0.21
TBC1D1 rs61731607 Ala384Pro C/G 6.25% 6.64% 0.704 0.24
TBC1D1 rs61731610 Gly389Ser A/G 6.87% 7.25% 0.818 0.53
TBC1D1 Arg443* C/T 0.00% 0.00% NA NA
TBC1D1 rs145177739 Gln619Arg A/G 0.00% 0.00% NA NA
TBC1D1 rs58983546 Arg695Cys C/T 24.86% 23.31% 1.362 0.05
TBC1D1 Leu838Val T/G 0.00% 0.00% NA NA
TBC1D1 rs376683121 Arg1091His A/G 0.85% 0.71% 1.5 0.65
TBC1D1 rs13110318 Arg1136Gln A/G 0.85% 1.16% 0.6 0.48
AA: Amino acid; EAF: Effect allele frequency; NA: not available; bold: Effect allele
doi:10.1371/journal.pone.0147904.t003
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located in the MSRA domain of the protein. In silico predictions for both variants range from
neutral to highly functional (Table 4).
Discussion
We aimed to identify new mutations with relevance for body weight regulation by targeted re-
sequencing (NGS) in the coding regions of six genes.
The gene TBC1D1 which was originally derived from animal studies contained most vari-
ants of all analyzed genes (17 total, of these 11 non synonymous, Table 1). SNP Arg695Cys
(rs58983546) was not associated with obesity in the initial sample (p = 1), but showed nominal
over-transmission of the 695Cys allele in the 355 obesity trios (p = 0.05; Table 3) and an
increased sample size of 705 trios (p = 0.03). In the latest GWAS meta-analysis for BMI, the
SNP was not associated with obesity (p = 0.38, [3]). We could not confirm the previously
described obesity association [8, 9] of variant Arg125Trp (p = 0.66) in 355 obesity trios. How-
ever, the allele frequency for the risk allele was higher in our index patients than in a population
based CEU sample (MAF in obese 0.17 vs. 0.07 in the ESP “NHLBI Exome Sequencing Project”
Table 4. Phenotypes of heterozygous carriers of rare non-synonymous variants in the screening sample and extended in silico analyses for the
respective variants.
Mutation Gender Age
[years]
BMI
[kg/m2]
BMI
SDS
In silico analyses
Gene Variant MutationTaster PMUT PolyPhen2 SIFT SNAP
Obese
FTO Ala163Thr female 17.01 35.86 2.83 disease
causing
Pathological
0.7261
Benign 0.042 Tolerated
1.00
Neutral
60%
FTO Ala163Thr female 16.20 40.28 3.37 disease
causing
Pathological
0.7261
Benign 0.042 Tolerated
1.00
Neutral
60%
SDCCAG8 Thr398Met male 14.87 40.94 3.17 disease
causing
Neutral 0.1646 Probably
damaging 0.998
Tolerated
0.90
Neutral
53%
TNKS Pro275Ala female 11.54 33.90 3.01 disease
causing
Neutral 0.3125 Benign 0.040 Tolerated
1.00
Neutral
85%
MSRA Arg6Glufs*88 female 13.62 42.67 3.51 disease
causing
/ / / /
MSRA Gly187Ser male 15.72 40.40 3.16 Polymorphism Neutral 0.4197 Benign 0.421 Not tolerated
0.01
Non-
neutral
58%
TBC1D1 Arg443* female 14.58 34.84 2.92 disease
causing
/ / / /
TBC1D1 Gln619Arg male 17.15 39.14 3.16 disease
causing
Neutral 0.2881 Probably
damaging 0.996
Tolerated
0.95
Non-
neutral
63%
TBC1D1 Leu838Val male 13.82 35.54 2.85 disease
causing
Neutral 0.1036 Probably
damaging 1.000
Not tolerated
0.51
Neutral
69%
TBC1D1 Arg1091His male 7.93 41.54 4.15 disease
causing
Neutral 0.4649 Benign 0.042 Tolerated
1.00
Neutral
60%
Lean
FTO Cys9Tyr female 21.78 18.05 -1.62 Polymorphism Neutral 0.3751 Benign 0.231 Not tolerated
0.45
Neutral
63%
FTO Val83Leu male 27.75 18.90 -2.40 disease
causing
Pathological
0.6685
Probably
damaging 0.998
Not tolerated
1.00
Non-
neutral
63%
MSRA Asp142Tyr female 27.78 17.78 -2.19 Polymorphism Neutral 0.4242 Probably
damaging 1.000
Not tolerated
1.00
Non-
neutral
87%
doi:10.1371/journal.pone.0147904.t004
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cohort, dbSNP), or in previous studies (MAF 0.02 in n = 940 [8]; MAF 0.09 in n = 1,109 [9]).
Both reported associations referred only to familial extreme obesity; in fact, Meyre et al. [9]
were not able to confirm their finding in a population based sample for mild obesity and over-
weight (n = 4,634). Although the initial positive association was based mainly on females [9],
we did not perform sex-stratified analyses as the allele frequency of the variant is too low for
sufficiently powered analyses in females only. SNP Ser14Pro (rs2279027) was not associated
with obesity in our study groups (Table 3).
All of the rare TBC1D1 variants (Arg443, Gln619Arg, Leu838Val, Arg1091His) were
detected in obese cases only (see Table 4). The mutation Arg443 was only detected heterozy-
gously in one extremely obese individual. The mutation leads to a loss of the Rab-GTPase-TBC
domain and thus presumably to a loss of function. Although Cheng et al. [59] described binding
of the Tbc1d1 protein to the adaptor protein APPL1 via N-terminal PTB domains, for signal
transduction to partners downstream of TBC1D1, a full Rab-GTPase-TBC domain is necessary.
For the other three variants, in silico prediction was rather mixed and conservation was not very
strong (Gln619Arg: 63% conservation, Leu838Val: 64% conservation, Arg1019His: 71% conser-
vation for 67 analyzed species; http://www.ensembl.org/).
In short, Arg443 is the functionally most relevant variant we detected in TBC1D1. Contrary
to our hypothesis, this variant was detected in an obese individual. Functional analyses are
therefore warranted. TBC1D1 SNP Arg695Cys (rs58983546) could contribute to the obesity
association of the gene. Hence, although the gene was initially identified in mice with diet
induced obesity resistance [5] our findings imply that loss of function and function-reducing
variants in humans might be relevant for obesity development.
For the most relevant obesity polygene FTO, our data are comparable to previous studies
[58, 60] as we also detected non-synonymous variants in both obesity and control study
groups. The obesity GWAS signals are localized to the first intron of FTO [61, 62] and appar-
ently do not affect the amino acid structure of the protein [58] but rather the expression of
FTO [24]. A recent study indicates that the obesity association of the first intron does not
imply FTO as the causal gene, but IRX3 located downstream on the same chromosome which
is regulated by the first intron of FTO [63]. The FTO variant Val83Leu, detected in a lean adult
male, has the highest potential for a functional impact as the in silico predictions for this vari-
ant all indicate an altered function which would be concordant with the mouse model (lean
phenotype in a knock out mouse). However, as the prediction methods can only analyze
change of function, this could also hint at an increased function. Hence, in vitro analysis of this
variant is highly warranted.
For SDCCAG8, previous mutation screens focused on obesity in patients with Bardet-Biedl
syndrome [32, 64] and revealed frameshift-, nonsense and loss of splicing enhancer mutations.
For the genes SDCCAG8, TNKS andMSRA, we expected to find variants leading to a reduced
protein function. However, the variants we detected were too infrequent for meaningful obesity
association analysis (SDCCAG8 [Thr398Met], TNKS [Pro275Ala],MSRA [Arg6GlufsX88],
[Asp142Tyr], [Gly187Ser]) or showed no obesity association (SDCCAG8 [Glu378Asp], TNKS
[Gly237Ala];MSRA [Thr88Met],). In detail:
(a) The frameshift variant inMSRA [Arg6Glufs88] was initially detected in an extremely
obese individual. The functional implications are presumably strong (in silico analyses). Only
two lean heterozygous mutation carriers were identified in an independent study group (243
extremely obese children and adolescents and 261 lean adult controls). An obese father of the
705 obesity trios did not transmit the variant his extremely obese offspring. Hence, an impact
of the mutation on body weight regulation is rather unlikely. (b) The other rare MSRA variant
(Gly187Ser) detected in an obese male was mainly predicted to be functionally irrelevant
(Table 4). It is located at a position which is not conserved (3% conservation among 68 species,
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http://www.ensembl.org/). (c) The rare variant Asp142Tyr inMSRA was detected in a lean
female (Table 4). It is also located in the MSRA domain of the protein. The amino acid position
142 was conserved between 68 species (conservation 71%, http://www.ensembl.org/). Taken
together, our findings hint that the detectedMSRAmutations are unlikely to be relevant for
weight regulation.
The two genes TNKS and SDCCAG8, derived from GWAS meta-analyses in extremely
obese children and adolescent, both harbored rare mutations only in the obese cases. The con-
servative variant Pro275Ala is located in a region of TNKS that is highly conserved (81% in 72
species, http://www.ensembl.org/). Nonetheless in silico prediction is mainly neutral (Table 4).
Conservation of amino acid position Thr398 is low (41% in 68 species, http://www.ensembl.
org/). In sum a strong impact of the detected mutations in TNKS and SDCCAG8 on obesity
cannot be derived from our data.
Limitations of our study include a small sample size, thus low power and the lack of func-
tional studies pertaining to the rare non-synonymous and frame shift mutations we discovered.
The respective in vitro functional studies are highly warranted as the predictive power of in sil-
ico programs is limited [65]. We did not correct for multiple testing as none of the variants was
reproducibly nominally associated with obesity.
In summary, we screened the coding regions of seven genes for variants leading to mono-
genic forms of obesity. For FTO, we detected, concordant with our hypothesis one rare variant
leading to a loss of FTO function in a lean individual. In TBC1D1 discordant to our hypothesis
the loss of function variant (Arg443) was found in an obese individual.
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